Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Shire exercises option to license candidate agent for CNS disorders

March 21, 2012

Cellceutix enters collaboration agreement to support Kevetrin development

March 20, 2012

CUNY to validate diagnostic antibodies

March 20, 2012

QRxPharma and Actavis sign new licensing agreement

March 20, 2012

Merck & Co. enters into collaboration to create new institute

March 20, 2012

Cartagenia enters partnership for rare epilepsy syndromes

March 20, 2012

Thrombogenics and Alcon enter commercialization agreement for ocriplasmin

March 16, 2012

Biogen Idec and MAKScientific enter MS agreement

March 16, 2012

Almirall attains new marketing rights to Sativex

March 16, 2012

Marina Biotech and ProNAi Therapeutics enter license agreement for DNAi-based therapies

March 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...